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 Background: Lithium has been commonly used for the treatment 
of several mood disorders particularly bipolar disorder in the last 
60 years. This study aimed to analyze patients with lithium 
intoxication referred to Loghman- Hakim teaching hospital. 
Methods: This is a cross sectional study that has been done on 108 
patients with lithium intoxication during 2001 to 2010. Necessary 
data were collected by checklists and then analyzed by statistical 
methods in SPSS version 20. 
Results: 39.8% of patients were male and most of them were in 
age group 20-40 years (47.2%). The rate of lithium use in 66.7% 
of patients was lower than 20 grams and the level of lithium in 
blood was 1 mEq/lit in 44.4% of patients. The rate of recovery has 
been significantly relation with BUN, creatinin, Intubation, pCO2 
and pH. There was a significant relation between hospitalized with 
pH, pCO2, Na, absorbent materials, intubation and bicarbonate. 
Conclusion: Results showed that we should note to the rate and 
time of lithium used and also severity of signs in management and 
treatment of patients with the lithium toxicity. 
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1. Introduction:
*
  
The use of lithium is recognized in the 
treatment of acute manic phases as well as in 
the prevention of recurrent manic or 
depressive episodes in bipolar disorder (1). 
Use of lithium in case of long-term 
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pharmacotherapy results in the appearance 
of cases of lithium toxicity (2-4). 
Therapeutic index of lithium is narrow (0.6 
to 1.2 mEq/L) and toxic threshold is around 
1.6 mmol/L. According to Sheehan (5), 
mortality due to acute lithium intoxication 
has been reported 15% (6).  
Clinical features of lithium acute 
intoxication are mostly neurological, and 
range from drowsiness, slight tremor, 
headache, apathy with slurred speech, 
muscle tremors. In most aspects there 
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appears serious coma, diffuse muscle 
twitching and convulsions. Associate 
digestive disorders such as nausea and 
vomiting and diarrhea may occur. Cardiac 
manifestations such as supraventricular 
arrhythmia are not common, and mostly 
isolated electrocardiographic changes (QT 
prolongation, changes in T wave) are 
reported (7). Kidney related events are not 
common during acute poisoning by lithium 
salts, and are often observed during chronic 
treatment, manifested by nephrogenic 
diabetes insipid us with polyuria, which may 
promote dehydration (8). 
Toxic manifestations are often reported in 
patients receiving long-term high doses of 
lithium: plasma half-life of Lithium can last 
12-58 hours in the absence of appropriate 
clinical management or in patients under 
long term (more than a year) treatment by 
the lithium (9). Prolonged treatment with 
carbonate lithium leads to intracellular 
accumulation of lithium which can explain 
the increased half–life lithium plasma level 
(10). This is independent of the dosage 
which in the sustained-release forms, delay 
intestinal absorption about 2-8 hours and the 
peak urinary excretion 8-24 hours. Other 
factors, such as renal failure inhibitors may 
be involved in the accumulation of lithium 
(11).  
In the present study, we aimed to determine 
the predictive factors on morbidity in 
patients with lithium intoxication referred to 
Loghman teaching hospital from 2001 to 
2010.  
 
2. Materials and Methods: 
This is a retrospective, cross sectional study 
that has been done on 108 patients with 
lithium intoxication from 2001 to 2010 in 
Loghman Hakim Hospital. Demographic 
data (age and gender) and other information, 
including vital signs at admission time, 
lithium plasma levels, electrocardiography 
findings, blood urea, sodium and potassium 
concentrations, neurologic findings, 
respiration condition and levels of 
consciousness, treatments and outcome was 
registered by a checklists. This study is 
approved by the medical ethic committee of 
Shahid Beheshti University of Medical 
Sciences. Collected data analyzed by 
descriptive and analytical statistical methods 
in SPSS 20. P<0.05 set as a significant. 
 
3. Results: 
The demographic and clinical data of the 
patients are illustrated in Table 1. A total of 
108 patients were analyzed that 39.8% of 
them were male and 60.2% were female. Of 
all, 47.2% were in an age group 20–40 year 
old. 59.3% of patients were admitted to 
hospital in less than six hours after lithium 
ingestion, while 13.9% were admitted 
between 6 to 12 hours after ingestion, 
and18.5% were taken to hospital more than 
12 hours. The amount of taken lithium was 
reported under 20 grams (gr) in 66.7% of 
patients, between 20-40 grams in10.2%, and 
more than 40 grams in 4.6%. 26.9% of 
patients had pure lithium toxicity; however 
70.4% had taken other drugs besides lithium. 
5.6% of patients noted a previous history of 
seizures, 60.2% had at least a psychiatric 
disorder, 36.1% had a history of previous 
suicide attempt, and4.6% had illicit drug 
addiction. 
All patients with pure lithium intoxication 
were successfully recovered, but in 3.9% of 
patients who had taken other drugs rather 
than lithium, complete recovery was not 
reported, which shows a significant 
difference (P=0.001).  
93.5% of patients were treated with activated 
charcoal and sorbitol and 1.9%, were treated 
with polyethylene glycol. 4 (7.3%) of 
patients were used as adsorbent. 13% of 
patients were hospitalized in intensive care 
unit , and 78.1% were hospitalized in wards. 
Lithium level in blood was measured<1 in 
44.4% of patients. 
There was a strong relationship between 
GCS and recovery. There was no recovery in 
two patients with a GCS of 15 (2%), but 
50% of patients who had a GCS less than 15 
(n=3) did not experience recovery 
(P=0.001). 
Furthermore, we found a significant relation 
between renal function tests (BUN and 
creatinine) and recovery. Complete recovery 
was reported in 100% of patients with BUN 
<8, but the recovery rate in patients with 
BUN levels among 8-25 and >25 was 7.16% 
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and 1.2 consecutively. Moreover, 1% of 
patients with creatinine clearance between 
0.5 up to1.7 showed symptoms of clinical 
progress, while recovery was not observed in 
44.4% of the group with Cr >1.7 
(P<0.001).10 patients (10.3%) were 
intubated, among them 3 (33.3%) patient did 
not recover, whereas in non-intubated 
patients, 2 (2.1%) of them did not recover, 
which is statistically significant (P<0.001). 
Furthermore, the length of hospitalization in 
intubated patients was more than non-
intubated ones (P=0.01). 
The length of hospitalization was also 
associated with the use of absorbent material 
and polyethylene glycol (P=0.001). Because 
of 101 patients who were treated with 
activated charcoal and sorbitol, 89.1% were 
hospitalized for less than 2 days, and in 
patients for whom polyethylene glycol was 
utilized, 50% had hospital stay length for 
more than 2 days.  
Patients’ length of stay was in relation with 
the admission time blood gas (PH and 
HCO3) as well. PH between 7.35-7.45 was 
reported in 95.7% of patients. 4 patients had 
hospitalization length >7 days, of which 
75% had normal PH and 25% had acidosis 
(P=0.009).  
We also detected a significant relation 
between blood PH and HCO3 and duration 
of ICU stay. Eight patients had one day ICU 
stay, among which, one had blood pH <7.35, 
but in the case of two other patients with 
Table 1: The mean of vital signs in patients by from of pill 
Male=43 (39.8%) 
Female=65 (60.2%) 
Gender 
<20 years 36 (33.3%) 
20-40=51 (47.2%) 
>40 (19.4%) 
Age 
<6 hrs=64 (59.3%) 
6-12 hrs=5 (13.9%) 
>12 hrs=20 (18.5%) 
Missing data =9 (8.5%) 
Admission to hospital (after intoxication ) 
<20 gr=72 (66.7%) 
20-40 gr=11 (10.2%) 
>40 gr= 5 (4.6%) 
Missing data=20 (18.5%) 
Lithium amount taken 
Lithium only=29 (26.9%) 
Lithium+other drugs=76 (70.4%) 
Drugs used by the 
GCS15=102 (94.4%) 
GCS<15=5 (5.6%) 
 
GCS 
Normal =105 (97.2%) 
Myosis=2 (1.9%) 
Decreased light reflex=1 (0.9%) 
Pupil size 
Active charcoal+Sorbitol=101 (93.5%) 
Polyethylene glycol=2 (1.9%) 
Conservative treatment=4 (3.7%) 
 
Clinical management method 
Yes=94 (87%) 
No=14 (13%) 
 
ICU hospitalization 
< 1 gr=48 (44.4%) 
1-2 gr=26 (24.1%) 
3 gr=7 (6.5%) 
4 gr=2 (1.9%) 
5gr=2 (1.9%) 
Amount of Lithium ingestion 
Seizures=0 
Nystagmus=0 
Tremor=4 (3.7%) 
Increased deep tendon reflexes=1 (0.9%) 
Decreased deep tendon reflexes=3 (2.8%) 
Neurologic manifestation 
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ICU stay> 1 day, blood pH was not normal 
(P=0.03). Also, in all 8 patients who were 
hospitalized for 1 day in the ICU, HCO3 was 
equal to 24 but in two patients who had ICU 
stay >1 day, HCO3 was reported <24 
(P=0.02). 
 
4. Discussion: 
Since the 1950s, lithium carbonate has been 
used in the treatment of bipolar depression 
(4), sustained release forms appeared in 
1994 on the market and provided stability 
with following lithium with a single dose 
daily. However, this practice exposes 
advantage to patients with prolonged 
treatment or involuntary intoxication effects.  
In such cases, treatment should be consisted 
of two successive sessions of hemodialysis 
due to rebound of the lithium level. Severe 
neurological clinical manifestations may 
occur after the first dialysis session. 
Dehydration remains a very common risk 
factor in such patients (12). Certain 
coincidental drugs are known to be related to 
dehydration: diuretics, non-steroid anti-
inflammatory drugs, tetracycline, 
cyclosporine, angiotensin converting enzyme 
(8). Besides, febrile conditions associated 
with neuroleptic malignant syndrome, 
surgery or infections, a secondary fluid and 
electrolyte disorder with renal failure or 
dehydration are risk factors for poisoning (5, 
13).  
Duration of intoxication before admission to 
hospital and individual tolerance are also 
contributory (12). According to one study 
(6), hyperthermia plays a major role in 
facilitating the intrinsic neurotoxicity of 
lithium by its ability to weaken the cell 
membranes. It may also induce a concept of 
lithium tolerance variable over time (14). It 
is important to consider risk factors to 
prevent poisoning.  
Lithium erythrocyte concentration may be a 
more accurate measurement of the lithium 
concentration in the brain (5). In case of 
severe intoxication where lithium levelis 
greater than 3.5 mmol/L, or when the 
patient's condition is unstable regardless of 
serum lithium levels, hemodialysis remains 
the treatment of choice (8). 
In a prospective study (15) selected 99 
schizophrenic patients older than 30 years 
under a national health study, with regular 
follow-up visits. After correction of 
cardiovascular disease, body mass index 
(BMI), blood pressure, cholesterol, HDL, 
exercise, smoking, alcohol, unnatural death 
and comorbid somatic diseases total 
mortality increased to 2.25 fold (95% CI3 
1.46 - 4.30), which increased with the 
number of neuroleptics treatments used. 
Causes of increased mortality were related to 
sudden arrhythmias (Torsades de Pointes), 
due to prolongation of the QT (ULN 440 ms, 
TdP risk from 500 ms) (16). There are also 
cases of sudden death without prolonged QT 
interval. Overall, mortality rate from suicide 
in people with schizophrenia diagnosis has 
been reported between 4% and 13% and on 
average about 10% (17).  
Table 2: Vital signs and lab tests at 
admission time 
Vital signs  
Blood pressure 
(mmHg) 
<120/80=87 (80.6%) 
120/80-140/90=7 (6.5%) 
>140/90=14 (12.9%) 
Heart rate 
(pulse/min) 
<60=3 (2.8%) 
60-100=102 (94.4%) 
>100=3 (2.8%) 
Respiration rate 
(per minute) 
 
<14=1 (0.9%) 
14-20=105 (97.2%) 
>20=2 (1.9%) 
Lab tests   
WBC <4*10
3
=1 (0.9%)
 
4-10*10
3
=80 (74.1%) 
>10*10
3
=26 (24.1%) 
Na <135= 3 (2.8%) 
135-145=99 (91.7%) 
>145=5 (4.6%) 
K <3.5=2 (1.9%) 
3.5-5.5=104 (96.3%) 
>5.5=1 (0.9%) 
BUN <8=2 (1.9%) 
8-25=81 (75%) 
>25=24 (22.2%) 
Cr 0.5-1.7=98 (90.7%) 
>1.7=9 (8.3%) 
PH <7.35=6 (5.6%) 
7.35-7.45=100 (90.7%) 
>7.45=1 (0.9%) 
HCO3 <24=7 (6.5%) 
24=90 (83.3%) 
>24=10 (9.3%) 
PCO2 <35=3 (2.8%) 
35-45=101 (93.5%) 
>45=3 (2.8%) 
PaO2 <80=1 (0.9%) 
80-105=106 (98.1%) 
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After the first psychotic episode suicide the 
leading cause of death in the first year is 
particularly common (18). Another survey 
found a 37 fold increase, but overall 1.2% 
rate of suicide in schizophrenic patients 
diagnosed in the first 3.5 years after the first 
episode in patients who discontinued 
antipsychotics. 38% of patients attempted 
suicide within the first month after tapering 
the neuroleptics (19). As any other drugs 
intoxication with lithium is not uncommon. 
In these cases, appropriate knowledge of 
lithium intoxication, risk factors and causes, 
facilitate rapid identification and more 
effective recovery, which will eliminate the 
possibility of sequels.  
In our study, we found a significant relation 
between Glasgow Coma scale (GCS) and 
recovery rate in patients; therefore special 
attention should be paid to this item at the 
first visit by the clinician. Moreover, a 
detailed history should be taken from the 
patients, while our results showed less 
recovery in patients with several drugs 
intoxication. In our study, the recovery rate 
in patients with impaired renal function tests 
(BUN and creatinine) was significantly less 
than the patients with normal BUN and 
creatinine; this reminds us to consider serial 
laboratory tests. 
 
5. Conclusion: 
With regard to the results of study, the 
clinician should pay attention to patient’s 
medical history (lithium daily dose, time of 
consumption, other drugs and simultaneous 
illness) and other key points such as baseline 
biochemical investigation and blood lithium 
level, as well as clues found in physical 
examination. Also the measurement of 
serum lithium concentration is not sufficient 
for prediction of lithium toxicity rate and 
patients prognosis. One of the limitations of 
our study was the small number of the 
studied patients in comparison to other 
studies, and better results could be attained 
from the study with higher number of 
selected samples. 
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